Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
about
Heparin (GAG-hed) inhibits LCR activity of human papillomavirus type 18 by decreasing AP1 binding.The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression.Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplificationNovel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprintingOverexpression of C/EBPbeta represses human papillomavirus type 18 upstream regulatory region activity in HeLa cells by interfering with the binding of TATA-binding protein.KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells.Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycleInterferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells.Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes.A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region.Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.An enhanced epithelial response of a papillomavirus promoter to transcriptional activators.The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.Site-directed mutagenesis of human papillomavirus 18 promoter elements and tissue-specific expression in cervical carcinoma cells.The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells.Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a.Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
P2860
Q33255972-E2F1ED2A-A57B-4CFD-BB8B-F9DEC9474A33Q33652913-5DF307F5-6D5B-4C0D-B7FE-B70AB3947FA0Q33724179-1953212A-A8E2-4A1B-A220-9C84C7DA8A83Q33782147-24D9D15F-BBFD-491A-B711-5B89EC736E89Q33782394-E1A523D3-61CD-4991-9085-BD82A6E11ABFQ33829316-12640911-4B16-4593-BB76-F363B28A2C69Q33853515-408A9D0A-D652-4D17-943E-EB061A7799DCQ34338428-1354001A-625B-495C-8725-9C3B2444E56AQ35072497-F791FB57-FA4B-4386-B08C-B7662011688EQ35845299-5AA091FC-8DF3-489F-8D76-5398E4CBE4D7Q35872068-790F09AF-F8D3-4B42-BC36-D7577AF96C23Q35899069-036E8A96-F4E7-4710-971B-7E8F4407382AQ36627345-CEEDB664-5856-48C5-AC61-E9CBB70306BDQ36636087-27B856EB-39ED-44C7-8A72-2868161BD9A1Q36636897-E2B1B66C-5B10-443F-A959-F2E1E6CD0028Q36943163-5C60F8E0-A537-4413-8B9F-7C43E7D1D2ADQ38314561-D5DE0C27-CFF8-4BA8-BA3B-88D4EBC528FAQ38320530-3FECC88C-47A6-493C-80F4-B3E11B0EDB72Q38875175-155EA7D2-C1C3-4CE8-8EC8-0289CC8FE13BQ39393237-4D090F20-8496-484A-A0C1-4FC7F54A0A2CQ39501471-DAEE7B68-61F7-4815-AE62-C3F3C30FD6C5Q39872915-2902AAD0-EC8A-4DC5-9A6F-D56EEE238F48Q40015385-E2CCF0DD-265D-4204-8822-09AA7C851E2BQ42829658-A2866A1B-E215-49DA-B99B-993830CC3654Q53176137-76FB007E-D0C6-4C80-A4AF-D99DC9A91A26
P2860
Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Activation of human papillomav ...... n by transcription factor Sp1.
@ast
Activation of human papillomav ...... n by transcription factor Sp1.
@en
type
label
Activation of human papillomav ...... n by transcription factor Sp1.
@ast
Activation of human papillomav ...... n by transcription factor Sp1.
@en
prefLabel
Activation of human papillomav ...... n by transcription factor Sp1.
@ast
Activation of human papillomav ...... n by transcription factor Sp1.
@en
P2860
P356
P1476
Activation of human papillomav ...... n by transcription factor Sp1.
@en
P2093
Hoppe-Seyler F
P2860
P304
P356
10.1093/NAR/20.24.6701
P407
P577
1992-12-01T00:00:00Z